- Issuer ticker
-
MAZE
- Reported as of
-
08 Jun 2026
- Net transaction value
-
$0
- SEC form
-
4
- Accepted by SEC
-
10 Jun 2026, 16:28:22 UTC
Filing notes and source
Key filing fact
Jonathan E. Lim filed Form 4 for Maze Therapeutics, Inc. (MAZE) on 10 Jun 2026.
Key facts
- This page summarizes Jonathan E. Lim's Form 4 filing for Maze Therapeutics, Inc. (MAZE).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 10 Jun 2026, 16:28.
Change
- Previous filing in this sequence was filed on 30 Jan 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001283290
Primary reporting owner
Lim Jonathan E
- Relationship
-
Director
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MAZE
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- Shares
- +18,000
- Change %
- Price
-
$0.000000*
- Shares after
- 18,000
- Date
- 08 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 18,000
- Exercise price
- $23.58
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote